NASDAQ:PETQ - PetIQ Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $76.25
  • Forecasted Upside: 155.44 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$29.85
▲ +0.36 (1.22%)
1 month | 3 months | 12 months
Get New PetIQ Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PETQ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PETQ

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$76.25
▲ +155.44% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for PetIQ in the last 3 months. The average price target is $76.25, with a high forecast of $175.00 and a low forecast of $35.00. The average price target represents a 155.44% upside from the last price of $29.85.
Buy
The current consensus among 4 investment analysts is to buy stock in PetIQ. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/3/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/1/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/30/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/28/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020OppenheimerReiterated RatingBuy$50.00Low
i
Rating by Brian Nagel at Oppenheimer Holdings Inc.
11/6/2020Raymond JamesLower Price TargetOutperform$43.00 ➝ $35.00High
i
8/17/2020GuggenheimBoost Price Target$130.00 ➝ $175.00Low
i
8/14/2020Raymond JamesLower Price TargetOutperform$44.00 ➝ $43.00Low
i
8/7/2020OppenheimerReiterated RatingBuy$50.00High
i
8/7/2020Raymond JamesBoost Price TargetOutperform$41.00 ➝ $44.00High
i
7/20/2020SunTrust BanksBoost Price TargetBuy$35.00 ➝ $45.00Low
i
Rating by William Chappell at SunTrust Banks, Inc.
7/1/2020Raymond JamesBoost Price TargetOutperform$35.00 ➝ $41.00Low
i
6/25/2020GuggenheimBoost Price TargetBuy$33.50 ➝ $44.00Medium
i
6/16/2020Raymond JamesBoost Price TargetOutperform$32.00 ➝ $35.00Medium
i
5/8/2020Raymond JamesLower Price TargetOutperform$33.00 ➝ $32.00High
i
Rating by Joseph Altobello at Raymond James
5/8/2020SunTrust BanksBoost Price TargetBuy$30.00 ➝ $35.00High
i
Rating by William Chappell at SunTrust Banks, Inc.
5/8/2020OppenheimerReiterated RatingBuyHigh
i
3/11/2020SunTrust BanksReiterated RatingBuy$45.00High
i
Rating by William Chappell at SunTrust Banks, Inc.
3/11/2020Raymond JamesLower Price TargetOutperform$40.00 ➝ $38.00High
i
Rating by Joseph Altobello at Raymond James
12/4/2019Raymond JamesReiterated RatingBuyLow
i
Rating by Joseph Altobello at Raymond James
5/23/2019GuggenheimInitiated CoverageBuy ➝ Buy$35.00Medium
i
3/4/2019Raymond JamesLower Price TargetOutperform ➝ Outperform$42.00 ➝ $39.00High
i
1/15/2019Jefferies Financial GroupReiterated RatingBuy$39.00High
i
11/14/2018Raymond JamesLower Price TargetOutperform ➝ Outperform$45.00 ➝ $42.00High
i
11/14/2018Jefferies Financial GroupBoost Price TargetBuy$42.00High
i
10/5/2018OppenheimerBoost Price TargetOutperform$28.00 ➝ $50.00Medium
i
9/28/2018CL KingInitiated CoverageBuy ➝ Buy$49.00Medium
i
9/19/2018Raymond JamesReiterated RatingBuy$33.00 ➝ $45.00High
i
8/24/2018Jefferies Financial GroupReiterated RatingBuyLow
i
8/15/2018SunTrust BanksBoost Price TargetBuy$40.00High
i
7/2/2018Jefferies Financial GroupBoost Price TargetBuy$30.00 ➝ $32.00High
i
5/16/2018Jefferies Financial GroupReiterated RatingBuy$30.00High
i
4/11/2018Jefferies Financial GroupReiterated RatingBuy$31.00Low
i
1/8/2018Jefferies Financial GroupReiterated RatingBuy$27.00High
i
11/20/2017Jefferies Financial GroupUpgradeHold ➝ Buy$26.00N/A
i
11/7/2017Jefferies Financial GroupBoost Price TargetHold$25.00 ➝ $26.00N/A
i
8/15/2017CIBCInitiated CoverageOutperform ➝ Outperform$28.00Low
i
8/15/2017Raymond JamesInitiated CoverageOutperform ➝ Outperform$26.00Low
i
8/15/2017OppenheimerInitiated CoverageOutperform$28.00Low
i
8/15/2017SunTrust BanksInitiated CoverageBuy ➝ Buy$28.00Medium
i
8/15/2017William BlairInitiated CoverageOutperform ➝ OutperformMedium
i
Rating by J. Andersen at William Blair
8/15/2017Jefferies Financial GroupInitiated CoverageHold ➝ Hold$25.00Medium
i
(Data available from 11/25/2015 forward)
PetIQ logo
PetIQ, Inc. operates as a pet medication and wellness company. It operates through two segments, Products and Services. The company offers prescription pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products The company offers its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. As of March 10, 2020, it operated through approximately 60,000 points of distribution across retail and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Read More

Today's Range

Now: $29.85
$29.33
$30.38

50 Day Range

MA: $29.81
$24.99
$34.54

52 Week Range

Now: $29.85
$15.83
$38.99

Volume

366,286 shs

Average Volume

382,958 shs

Market Capitalization

$856.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.56